by Lupus Foundation, Ohio | Mar 12, 2026 | Lupus Foundation of America, News & Events
The Fast Track designation was supported by positive topline results from its Phase 2b JASMINE study. This post was originally published on this...
by Lupus Foundation, Ohio | Mar 11, 2026 | Lupus Foundation of America, News & Events
New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus. This post was originally published on this...
by Lupus Foundation, Ohio | Mar 3, 2026 | Lupus Foundation of America, News & Events
A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis (LN). This post was originally published on this...
by Lupus Foundation, Ohio | Feb 24, 2026 | Lupus Foundation of America, News & Events
A new study found that people with cytomegalovirus (CMV) infection may be more likely to develop systemic lupus erythematosus (SLE), and CMV could influence how the disease starts. This post was originally published on this...
by Lupus Foundation, Ohio | Feb 19, 2026 | Lupus Foundation of America, News & Events
A new study found statin use is associated with reduced disease activity and inflammation in people with systemic lupus erythematosus (SLE), particularly in patients younger than 40 years. This post was originally published on this...
